Skip to main content
. 2002 May 4;324(7345):1072. doi: 10.1136/bmj.324.7345.1072

Box 2.

Source of information for trial outcomes

Primary outcome
Clinical
Stand-up test group—patient interview
Dot in square score—patient interview
Mortality—NHS Central Registry
Proportion sustaining fracture—patient interview
Patient wellbeing
PDQ-39 questionnaire—patient completed
Euroqol—patient interview
Global subjective wellbeing question—patient completed
Healthcare costs
Institutional, respite, hospital, day care, medication, community and general practitioner care, social security benefits, home aids and adaptations—patient interview
Nurse specialists in Parkinson's disease—costs based on NHS scales
Secondary outcome
Medication
Median dose levodopa—patient interview
Proportion of patients on levodopa controlled release preparation—patient interview
Proportion of patients receiving more than monotherapy—patient interview
Referral
Proportion of patients referred to ancillary therapy—patient interview
Proportion of patients referred to specialist for Parkinson's disease—patient interview